Ischemic preconditioning decreases apoptosis in rat hearts in vivo

Circulation

Volumn 96, Issue 5, 1997, Pages 1598-1604

  Piot, Christophe A ^a   Padmanaban, Devi ^a   Ursell, Philip C ^a   Sievers, Richard E ^a   Wolfe, Christopher L ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UCSF Medical Center at Parnassus   (United States)

Author keywords

Apoptosis; Ischemia; Myocardial infarction; Reperfusion

Indexed keywords

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; FEMALE; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030760513     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.5.1598     Document Type: Article

References (48)

1. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74:1124-1136.
2. Hagar JM, Hale SL, Kloner RA. Effect of preconditioning ischemia on reperfusion arrhythmias after coronary artery occlusion and reperfusion in the rat. Circ. Res. 1991;68:61-68.
3. Osada M, Sato T, Komori S, Tamura K. Protective effect of preconditioning on reperfusion induced ventricular arrhythmias of isolated rat hearts. Cardiovasc Res. 1991;25:441-444.
4. Urabe K, Miura TM, Iwamoto TI, Ogawa T, Goto M, Sakamoto J, Iimura O. Preconditioning enhances myocardial resistance to post-ischemic myocardial stunning via adenosine receptor activation. Cardiovasc Res. 1993;27:657-662.
5. Cohen MV, Liu GS, Downey JM. Preconditioning causes improved wall motion as well as smaller infarcts after transient coronary occlusion in rabbits. Circulation. 1991;84:341-349.
6. Schott RJ, Rohmann S, Braun ER, Schaper W. Ischemic preconditioning reduces infarct size in swine myocardium. Circ Res. 1990; 66:113-142.
7. Li Y, Whittaker P, Kloner RA. The transient nature of the effect of ischemic preconditioning on myocardial infarct size and ventricular arrhythmias. Am Heart J. 1992;123:346-353.
8. Liu Y, Downey JM. Ischemic preconditioning protects against infarction in rat heart. Am J Physiol. 1992;263:H1107-H1112.
9. Wolfe CL, Sievers RE, Visseren FL, Donnelly TJ. Loss of myocardial protection after preconditioning correlates with the time course of glycogen recovery within the preconditioned segment. Circulation. 1993;87:881-892.
10. Barbosa A, Sievers RE, Zaugg CE, Wolfe CL. Preconditioning ischemia time determines the degree of glycogen depletion and infarct size reduction in rat hearts. Am Heart J. 1996;131:224-230.
11. Muller DWM, Topol EJ, Califf RM, Sigmon KN, Gorman L, George BS, Kereiakes DJ, Lee KL, Ellis SG, Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. Relationship between antecedent angina pectoris and short term prognosis after thrombolytic therapy for acute myocardial infarction. Am Heart J. 1990;119:224-231.
12. Deutsch E, Berger M, Kussmaul WG, Hirshfeld JW, Herrmann HC, Laskey WK. Adaptation to ischemia during percutaneous transluminal coronary angioplasty: clinical hemodynamic and metabolic features. Circulation. 1990;82:2044-2051.
13. Yellon DM, Alkhulaifi AM, Pugsley WB. Preconditioning the human myocardium. Lancet. 1993;342:276-277.
14. Ottani F, Galvani M, Ferrini D, Sorbello F, Limonetti P, Pantoli D, Rusticali F. Prodromal angina limits infarct size: a role for ischemic preconditioning. Circulation. 1995;91:291-297.
15. Bing OHL. Hypothesis: apoptosis may be a mechanism for the transition to heart failure with chronic pressure overload. J Mol Cell Cardiol. 1994;26:943-948.
16. James TN, Nichols MM, Sapire DW, DiPatre PL, Lopez SM. Complete heart block and fatal right ventricular failure in an infant. Circulation. 1996;93:1588-1600.
17. Sharov VG, Sabbah HN, Shimoyama H, Goussev AV, Lesch M, Goldstein S. Evidence of cardiocyte apoptosis in myocardium of dogs with chronic heart failure. Am J Pathol. 1996;148:141-149.
18. Narula J, Haider N, Virmani R, Disalvo TG, Kolodgie FD, Hajjar RJ, Schmidt U, Semigran MJ, Dec WG, Khaw B. Apoptosis in myocytes in end-stage heart failure. N Engl J Med. 1996;335:1182-1189.
19. Umansky SR, Cuenco GM, Khutzian SS, Barr PJ, Tomei LD. Post-ischemic apoptotic death of rat neonatal cardiomyocytes. Death Differentiation. 1995;2:235-241.
20. Gottlieb RA, Burleson KO, Kloner RA, Babior BM, Engler RL. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest. 1994;94:1621-1628.
21. Walker PR, Sikorska M. Endonuclease activities, chromatin structure, and DNA degradation in apoptosis. Biochem Cell Biol. 1994;72:615-623.
22. Kajstura J, Cheng W, Reiss K, Clark WA, Sonnenblick EH, Krajewski S, Reed JC, Olivetti G, Anversa P. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest. 1996;74:86-107.
23. Raff MC. Social controls on cell survival and cell death. Nature. 1992;356:397-400.
24. Williams GT, Smith CA. Molecular regulation of apoptosis: genetic controls on cell death. Cell. 1993;74:777-779.
25. Kiefer MC, Brauer MJ, Powers VC, Wu JJ, Umansky SR, Tomei LD, Barr PJ. Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature. 1995;374:736-739.
26. Kajstura J, Mansukhani M, Cheng W, Reiss K, Krajewski S, Reed JC, Quaini F, Sonnenblick EH, Anversa P. Programmed cell death and the expression of the protooncogene bcl-2 in myocyte during postnatal maturation of the heart. Exp Cell Res. 1995;219:110-121.
27. Gottlieb RA, Gruol DL, Zhu JY, Engler RL. Preconditioning in rabbit cardiomyocytes: role of pH, vacuolar proton ATPase, and apoptosis. J Clin Invest. 1996;97:2391-2398.
28. Hutter MM, Sievers RE, Barbosa V, Wolfe CL. Heat-shock protein induction in rat hearts: a direct correlation between the amount of heat-shock protein induced and the degree of myocardial protection. Circulation. 1994;89:355-360.
29. Auyeung Y, Sievers RE, Weng D, Barbosa V, Wolfe CL. Catalase inhibition with 3-amino-1,2,4-triazole does not abolish infarct size reduction in heat-shocked rats. Circulation. 1995;92:3318-3322.
30. Gorczynca W, Bruno S, Darzynkiewicz RJ, Gong J, Darzynkiewicz Z. DNA strand breaks occurring during apoptosis: their early in situ detection by the terminal deoxynucleotidyl transferase and nick translation assays and prevention by serine protease inhibitors. Int Oncol. 1992;1:639-648.
31. Leist M, Gantner F, Bohlinger Ines, Germann PG, Tiegs G, Wendel A. Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-α requires transcriptional arrest. J Immunol. 1994;153: 1778-1787.
32. Ganote CE, Armstrong S, Downey JM. Adenosine and A1 selective agonists offer minimal protection against ischaemic injury to isolated rat cardiomyocytes. Cardiovasc Res. 1993;27:1670-1676.
33. Li Y, Kloner RA. The cardioprotective effects of ischemic 'preconditioning' are not mediated by adenosine receptors in rat hearts. Circulation. 1993;87:1642-1648.
34. Grover GJ, Dzwonczyk S, Sleph PG, Sargent CA. The ATP-sensitive potassium channel blocker glibenclamide (glyburide) does not abolish preconditioning in isolated ischemic rat hearts. J Pharmacol Exp Ther. 1993;265:559-564.
35. 1B-adrenoceptors, pertussis toxin-sensitive G proteins, and protein kinase C. Circulation. 1995;92:2259-2265.
36. Li Y, Kloner RA. Does protein kinase C play a role in ischemic preconditioning in rat hearts? Am J Physiol. 1995;268:H426-H431.
37. Speechly-Dick ME, Mocanu MM, Yellon DM. Protein kinase C: its role in ischemic preconditioning in the rat. Circ Res. 1994;75:586-590.
38. Kitakaze M, Node K, Minamino T, Komamura K, Funaya H, Shinozaki Y, Chujo M, Mori H, Inoue M, Hori M, Kamada T. Role of activation of protein kinase C in the infarct size-limiting effect of ischemic preconditioning through activation of ecto-5′-nucleotidase. Circulation. 1996;93:781-791.
39. 1-Adrenergic agonists precondition rabbit ischemic myocardium independent of adenosine by direct activation of protein kinase C. Circulation. 1994; 75:576-585.
40. Kida M, Fujiwara H, Ishida M, Kawai C, Ohura M, Miura I, Yabuuchi Y. Ischemic preconditioning preserves creatine phosphate and intracellular pH. Circulation. 1991;84:2495-2503.
41. de Albuquerque CP, Gerstenblith G, Weiss RG. Importance of metabolic inhibition and cellular pH in mediating preconditioning contractile and metabolic effects in rat hearts. Circ Res. 1994;74:139-150.
42. Schaefer S, Carr LJ, Prussel E, Ramasamy R. Effects of glycogen depletion on ischemic injury in isolated rat hearts: insights into preconditioning. Am J Physiol. 1995;268:H935-H944.
43. Tanaka M, Ito H, Adachi S, Akimoto H, Nishikawa T, Kasajima T, Marumo F, Hiroe M. Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes. Circ Res. 1994;75:426-433.
44. Piot C, Wolfe CL. Apoptosis: a new mechanism of lethal myocardial reperfusion injury? J Thromb Thrombol. 1997;4:67-68.
45. Tompson CB. Apoptosis in the pathogenesis and treatment of disease. Science. 1995;267:1456-1462.
46. Misao J, Hayakawa Y, Ohno M, Kato S, Fujiwara T, Fujiwara H. Expression of bcl-2 protein, an inhibitor of apoptosis, and Bax, an accelerator of apoptosis, in ventricular myocytes of human hearts with myocardial infarction. Circulation. 1996;94:1506-1512.
47. Gottlieb RA, Giesing HA, Zhu JY, Engler RL, Babior BM. Cell acidification in apoptosis: granulocyte colony-stimulating factor delays programmed cell death in neutrophils by up-regulating the vacuolar proton ATPase. Proc Natl Acad Sci U S A. 1995;92:5965-5968.
48. Caceres-Cortes J, Rajotte D, Dumouchel J, Haddad P, Hoang T. Product of the Steel locus suppresses apoptosis in hemopoietic cells: comparison with pathways activated by granulocyte macrophage colony-stimulating factor. J Biol. Chem. 1994;269:12084-12091.